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1. INTRODUCTION {#mbo3930-sec-0001}
===============

Many natural products are structurally too complex to be economically synthesized through purely chemical means, while also being present in low quantities in their natural sources (Pitera, Paddon, Newman, & Keasling, [2007](#mbo3930-bib-0035){ref-type="ref"}; Wu et al., [2016](#mbo3930-bib-0052){ref-type="ref"}). With the development of metabolic engineering technologies and synthetic biology tools, microbial cell factories were constructed to heterologously produce such chemicals and natural products (Leonard, Lim, Saw, & Koffas, [2007](#mbo3930-bib-0024){ref-type="ref"}; Pitera et al., [2007](#mbo3930-bib-0035){ref-type="ref"}; Watts, Mijts, & Schmidt‐Dannert, [2005](#mbo3930-bib-0050){ref-type="ref"}).

An efficient synthetic pathway for the target product is a *sine qua non* for the successful development of a cell factory. However, unwanted byproducts and intermediates can sometimes be accumulated in an unbalanced pathway and affect the pathway efficiency and final product yield (Berry, Dodge, Pepsin, & Weyler, [2002](#mbo3930-bib-0005){ref-type="ref"}; Keasling, [2010](#mbo3930-bib-0021){ref-type="ref"}; Xu, Gu, et al., [2013](#mbo3930-bib-0054){ref-type="ref"}; Zhu, Lawman, & Cameron, [2002](#mbo3930-bib-0061){ref-type="ref"}). Furthermore, some intermediates or heterologous enzymes are cytotoxic to the host cell once accumulated (Barbirato, Grivet, Soucaille, & Bories, [1996](#mbo3930-bib-0003){ref-type="ref"}; Harcum & Bentley, [1999](#mbo3930-bib-0016){ref-type="ref"}; Pitera et al., [2007](#mbo3930-bib-0035){ref-type="ref"}). Therefore, balancing the metabolic pathway is a universal strategy for cell factory engineering (Pitera et al., [2007](#mbo3930-bib-0035){ref-type="ref"}), which normally involves optimizing the transcriptional and translational levels of pathway genes (Brynildsen, Wong, & Liao, [2005](#mbo3930-bib-0008){ref-type="ref"}; Jin et al., [2017](#mbo3930-bib-0019){ref-type="ref"}; Xu, Gu, et al., [2013](#mbo3930-bib-0054){ref-type="ref"}; Xu, Li, Zhang, Stephanopoulos, & Koffas, [2014](#mbo3930-bib-0055){ref-type="ref"}; Xu, Vansiri, Bhan, & Koffas, [2012](#mbo3930-bib-0057){ref-type="ref"}). To optimize a pathway with multiple enzymes, it is ideal to analyze all possible expression levels of pathway genes in a combinatorial fashion. Several strategies and methods can be used to construct plasmid libraries encoding as many of the possible expression level combinations as possible (Chen et al., [2005](#mbo3930-bib-0010){ref-type="ref"}; Zaslaver et al., [2006](#mbo3930-bib-0058){ref-type="ref"}), or directly modulate multiple genes on the chromosome (Zhu et al., [2017](#mbo3930-bib-0062){ref-type="ref"}). Published approaches include the modulation of promoters (Cox, Surette, & Elowitz, [2007](#mbo3930-bib-0011){ref-type="ref"}; Xu, Rizzoni, Sul, & Stephanopoulos, [2017](#mbo3930-bib-0056){ref-type="ref"}) and ribosome‐binding sites (RBSs) (Salis, Mirsky, & Voigt, [2009](#mbo3930-bib-0041){ref-type="ref"}), manipulation of intergenic regions (Pfleger, Pitera, Smolke, & Keasling, [2006](#mbo3930-bib-0034){ref-type="ref"}), dynamic promoter regulation (Farmer & Liao, [2000](#mbo3930-bib-0015){ref-type="ref"}; Xu, Bhan, & Koffas, [2013](#mbo3930-bib-0053){ref-type="ref"}; Zhang, Carothers, & Keasling, [2012](#mbo3930-bib-0059){ref-type="ref"}), organelle compartmentalization of pathways (Avalos, Fink, & Stephanopoulos, [2013](#mbo3930-bib-0002){ref-type="ref"}; Farhi et al., [2011](#mbo3930-bib-0014){ref-type="ref"}), and modulation of DNA copy numbers (Juminaga et al., [2012](#mbo3930-bib-0020){ref-type="ref"}). These strategies involved direct employment of regulators and could generate a wide dynamic range to benefit for pathway optimization, but they also require manipulation of relatively long sequences and can be complex to operate, which makes more convenient strategies highly desirable.

The initiation codon contains only three nucleotides, yet it significantly affects the gene expression strength at the translational level (Looman et al., [1987](#mbo3930-bib-0027){ref-type="ref"}). ATG is the most common codon, but GTG, and more rarely TTG, is also employed by some genes (Aiba et al., [1984](#mbo3930-bib-0001){ref-type="ref"}; Danchin, Guiso, Roy, & Ullmann, [1984](#mbo3930-bib-0012){ref-type="ref"}). It was found that GTG has a lower translation initiation efficiency than ATG, and sometimes, ATG was used to replace GTG to increase target gene expression (Reddy, Peterkofsky, & McKenney, [1985](#mbo3930-bib-0037){ref-type="ref"}), which suggested that various codons among the exhaustive 64 combinations in an NNN library might lead to different initiation efficiency. Thus, it might be feasible to gradually modulate gene expression by changing the initiation codons. In this work, we found that the expression of reporter proteins RFP, GFP, and lacZ could be modulated by changing only the three nucleotides of their initiation codons. As intended, the expression libraries with genes initiated by random NNN codons indeed showed a large dynamic range and mostly evenly distributed expression levels. Due to the simplicity of manipulating only three or fewer nucleotides of the initiation codon, future methods using our approach might be much simpler than current strategies. Thus, a novel strategy of combinatorial modulation of initial codons (CMIC) was developed for metabolic pathway optimization in this work, which offers great flexibility at minimal costs of experimental materials and time.

Carotenoids were reported to be beneficial for the treatment and prevention of many diseases (Bourcier de Carbon, Thurotte, Wilson, Perreau, & Kirilovsky, [2015](#mbo3930-bib-0007){ref-type="ref"}; Farmer & Liao, [2000](#mbo3930-bib-0015){ref-type="ref"}; Sajilata, Singhal, & Kamat, [2008](#mbo3930-bib-0040){ref-type="ref"}), acting as effective antioxidants (Sies & Stahl, [1998](#mbo3930-bib-0043){ref-type="ref"}), as well as inhibitors of age‐related macular degeneration (Moeller, Jacques, & Blumberg, [2000](#mbo3930-bib-0029){ref-type="ref"}; Nishino, Murakoshi, Tokuda, & Satomi, [2009](#mbo3930-bib-0030){ref-type="ref"}) and cataract formation (Moeller et al., [2000](#mbo3930-bib-0029){ref-type="ref"}). Zeaxanthin, which is derived from the central carotenoid synthesis intermediates lycopene and β‐carotene, was reported to be vital in protecting the retina from damage (Stahl & Sies, [2005](#mbo3930-bib-0044){ref-type="ref"}; Thomson et al., [2002](#mbo3930-bib-0049){ref-type="ref"}) and also is regarded as an antioxidant (Krinsky & Johnson, [2005](#mbo3930-bib-0022){ref-type="ref"}; Whitehead, Mares, & Danis, [2006](#mbo3930-bib-0051){ref-type="ref"}). It is synthesized from phytoene via a short pathway comprising the enzymes crtI (phytoene desaturase), crtY (lycopene β‐cyclase), and crtZ (β‐carotenoid hydroxylase) (Sun et al., [2014](#mbo3930-bib-0046){ref-type="ref"}; Zhao et al., [2013](#mbo3930-bib-0060){ref-type="ref"}). In this work, the zeaxanthin synthesis pathway containing three gene products was optimized using CMIC to illustrate the application of this novel technique in *E. coli*.

2. MATERIALS AND METHODS {#mbo3930-sec-0002}
========================

2.1. Strains, media, and culture conditions {#mbo3930-sec-0003}
-------------------------------------------

The strains and plasmids used in this study are listed in Table [A1](#mbo3930-tbl-0002){ref-type="table"}. *E. coli* was cultured at 37°C in Lysogeny broth (10 g/L Difco tryptone, 5 g/L Difco yeast extract, and 10 g/L NaCl). The carotenoid fermentation medium was composed of (per liter) 10 g tryptone, 5 g yeast extract, and 10 g NaCl; 2% glycerol (v/v) was added to LB (Lysogeny broth) + glycerol. Apramycin sulfate (50 mg/L; Ruitaibio), chloramphenicol (34 mg/L; Solarbio), ampicillin (100 mg/L; Solarbio), kanamycin (50 mg/L; Solarbio), or β‐D‐1‐thiogalactopyranoside (IPTG, 1 mmol/L; Solarbio) were added to the media, where appropriate. Plasmids were extracted using the Bacterial Genomic DNA Miniprep Kit (Axygen Biosciences). Polymerase chain reaction (PCR) products were digested with DpnI for 0.5 hr at 37°C and then purified using a SanPrep Gel Extraction Kit (Sangon Biotech). Plasmids and PCR products were sequenced using Sanger sequencing (GenScript Co., Ltd).

2.2. Construction of the reporter expression libraries pNNNrfp, pNNNgfp, and pNNNlacZ {#mbo3930-sec-0004}
-------------------------------------------------------------------------------------

The primers pBBR1‐rfp‐F and pBBR1‐rfp‐R were used to amplify the backbone of pNNNrfp from plasmid pBBR1‐rfp, and the *rfp* gene was cloned into the pNNNrfp plasmid with kanamycin‐resistance cassette and pBBR1 replication origin, driven by the constitutive promoter BBa J23100 (Table [A2](#mbo3930-tbl-0003){ref-type="table"}). The initiation codon library NNN was embedded into the forward primer pBBR1‐rfp‐F. The resulting PCR product was digested with *Dpn*I to eliminate the PCR template and self‐ligated using Golden Gate DNA assembly (Hillson, Rosengarten, & Keasling, [2012](#mbo3930-bib-0018){ref-type="ref"}).

The GFP expression library pNNNgfp contained quite different components from those used to construct pNNNrfp, to construct pNNNgfp, the backbone fragment containing a pMB1 origin of replication and an apramycin‐resistance cassette was amplified from plasmid p034apr using the primer pair pMB1_apr_F and pMB1_apr_R; the constitutive promoter P46 (Table [A2](#mbo3930-tbl-0003){ref-type="table"}) was amplified from the strain M1‐46 using the primers p46‐up and GFP_RBS‐down containing the randomized initiation codon NNN; the *gfp* gene was cloned from plasmid pQE60‐gfp.

To construct the *lacZ* library pNNNlacZ, the backbone fragment comprising a pMB1 origin of replication and an apramycin‐resistance cassette was amplified from plasmid p034apr using the primer pair pMB1_apr_F and pMB1_apr_R; the constitutive P46 promoter (Table [A2](#mbo3930-tbl-0003){ref-type="table"}) was amplified from strain M1‐46 using the primers p46‐up and lacZ_RBS‐down containing the randomized initiation codon NNN; the *lacZ* gene was cloned from *E. coli* MG1655 using the primers LacZ_F and LacZ_R. The resulting plasmid libraries pNNNrfp, pNNNgfp, and pNNNlacZ were transferred into *E. coli* DH5α (CWBIO) and selected overnight on the LB plates with the corresponding antibiotics. The resulting colonies were used for expression analysis. All primers used in library construction are listed in Table [A3](#mbo3930-tbl-0004){ref-type="table"} and the sequencing primers in Table [A4](#mbo3930-tbl-0005){ref-type="table"}.

2.3. Construction of pCrtZYIlib libraries for combinatorial modulation of initial codons {#mbo3930-sec-0005}
----------------------------------------------------------------------------------------

To construct the combinatorial modulated plasmid library, primers crt‐F and crt‐R were used to amplify the backbone of the pCrtZYIlib from the plasmid pYL‐crtZYI with a pSC101 replication origin and a chloramphenicol‐resistance cassette; promoter 36 was amplified from the strain M1‐36 using primers P36‐F and P36‐R; and the *crtZ* gene was amplified from the plasmid pYL‐crtZYI using primers crtZ‐F and crtZ‐R, with the randomized initiation codon NNN embedded in the primer crtZ‐F. The *crtY* gene was amplified from the plasmid pYL‐crtZYI using the NNN‐containing primers crtY‐F and crtY‐R. The *crtI* gene was amplified from the plasmid pYL‐crtZYI using primers crtI‐F and crtI‐R with the same strategy. All the DNA fragments were digested using *Dpn*I at 37°C for 0.5 hr and ligated using the Golden Gate method (Hillson et al., [2012](#mbo3930-bib-0018){ref-type="ref"}). All primers used in library construction are listed in Table [A3](#mbo3930-tbl-0004){ref-type="table"} and the sequencing primers in Table [A4](#mbo3930-tbl-0005){ref-type="table"}.

2.4. Zeaxanthin production levels of different clones from the CMIC library {#mbo3930-sec-0006}
---------------------------------------------------------------------------

All CMIC library colonies were scraped from the plates and pooled for plasmid DNA extraction. The resulting plasmid library was transferred into the chassis strain PHY01 and grown overnight on LB/chloramphenicol plates. The resulting single colonies were picked from the plates and used to inoculate 15 mm × 100 mm tubes containing 3 ml of LB with 34 mg/L chloramphenicol and grown at 37°C and 250 rpm overnight. Aliquots comprising 100 μl of the resulting seed cultures were used to inoculate 100‐ml flasks containing 10 ml LB + 2% (v/v) glycerol carotenoid fermentation medium, and grown aerobically at 30°C and 250 rpm for 48 hr. The resulting fermentation cultures were collected for measurement of carotenoid production and biomass (OD~600 nm~).

2.5. RFP and GFP fluorescence measurement {#mbo3930-sec-0007}
-----------------------------------------

The RFP‐ and GFP‐expressing colonies were picked and transferred into 15 mm × 100 mm tubes containing 3 ml LB with 50 mg/L kanamycin and 50 mg/L apramycin, respectively, and grown at 37°C and 250 rpm overnight. The cultures were then inoculated into 15 mm × 100 mm tubes containing 3 ml LB with 50 mg/L with the same antibiotics and grown at 37°C and 250 rpm for 20 hr. Subsequently, 50 μl samples of each culture were transferred into individual wells of a 96‐well plate and diluted four times with LB. The blank control was 200 µl of pure LB. The optical density at 600 nm (OD~600 nm~) was measured for determining the biomass concentration using an SP‐723 spectrophotometer (Spectrum SHANGHAI). Fluorescence was measured at a gain of 60, using an excitation wavelength of 585 nm emission wavelength of 620 nm for RFP, 488 and 520 nm, respectively, for GFP, using an Infinite M200 Pro ELISA spectrometer (Tecan).

2.6. Measurement of*lacZ* expression {#mbo3930-sec-0008}
------------------------------------

A quantitative estimate of lacZ expression was obtained by measuring the β‐galactosidase activity using ortho‐nitrophenyl‐β‐D‐galactopyranoside (ONPG; Sigma) as a colorimetric substrate. Colonies grown on LB/apramycin plates at 37°C overnight were used to inoculate 15 mm × 100 mm tubes containing 4 ml LB with 50 mg/L apramycin and cultured for 4 hr at 37°C. The resulting actively growing mid‐log cultures were incubated on ice for 20 min to stop the growth and collected by centrifugation at 1,500 *g* and 4°C for 10 min. The resulting cell pellet was resuspended in the same volume of Z buffer (per 50 ml: 0.80 g Na~2~HPO~4~∙7H~2~O \[0.06 M\], 0.28 g NaH~2~PO~4~∙H~2~O \[0.04 M\], 0.5 ml 1 M KCl \[0.01 M\], 0.05 ml 1 M MgSO~4~ \[0.001 M\], 0.135 ml β‐mercaptoethanol (BME) \[0.05 M\], pH 7.0), and the cell density was measured at OD~600 nm~ using Z buffer as the blank. For enzyme activity measurements, 50 μl of cell suspension was added to 950 μl of Z buffer, permeated by adding 100 μl chloroform and 50 μl 0.1% SDS, and whirled for 30 S with a vortex mixer. The reaction was started by adding 200 μl 4 mg/ml ONPG and vortexing, continued for 1.5 min at 28°C, and stopped by adding 0.5 ml 1 M Na~2~CO~3~ solution. The absorbance at 420 and 550 nm was measured for each sample. The units of activity were calculated using the formula Miller Units = 1,000 × \[(OD~420~ -- 1.75 × OD~550~)\]/(*T* × *V* × OD~600~), where *T* = reaction time in minutes and *V* = volume of culture used in the assay in ml (Kumari, Panesar, & Panesar, [2004](#mbo3930-bib-0023){ref-type="ref"}; Otsuka, Nakabeppu, & Sekiguchi, [1985](#mbo3930-bib-0033){ref-type="ref"}).

2.7. Measurement of carotenoid production of clones from the CMIC library {#mbo3930-sec-0009}
-------------------------------------------------------------------------

An aliquot comprising 1 ml of each culture was harvested by centrifugation at 12,000 *g* for 5 min, suspended in 1 ml acetone, incubated at 55°C for 15 min in dark, and centrifuged at 12,000 *g* for 10 min. The acetone supernatants containing the carotenoids were transferred into fresh tubes for HPLC analysis. The HPLC was conducted on a Technologies Series 1200 system (Agilent) equipped with a VWD detector at 476 nm and a Symmetry C18 column (250 mm × 4.6 mm, 5 μm, Waters). A mixed gradient flow elution at a flow rate of 0.8 ml/min at 30°C containing mobile phase C (methanol, acetonitrile, and dichloromethane at 21:21:8, by volume) and phase D (10% methanol \[v/v\]) was employed to separate the analytes as described previously (Li et al., [2017](#mbo3930-bib-0025){ref-type="ref"}). The dry cell weight (DCW) was calculated from the optical density at 600 nm using the empirical formula 1 OD~600~ = 0.323 g DCW/L. The results are shown as the means ± *SD* of three repeated experiments.

2.8. Total RNA extraction and qRT‐PCR analysis {#mbo3930-sec-0010}
----------------------------------------------

In order to investigate the relationship between non‐ATG initial codons and the transcriptional expression levels of the key carotenoid synthetic pathway genes, two representative strains PHY01(pCrtZYI7) and PHY01(pCrtZYI9) and the control strain PHY01(pCrtZYIATG) were chosen to analyze the strength of the gene expression through real‐time qPCR (RT‐qPCR). Total RNA was extracted and prepared using the RNAprep Pure Plant Kit (Qiagen, DP441). For preparing the cDNA, reverse transcription was conducted using the *TransScript* II All‐in‐One First‐Strand cDNA Synthesis SuperMix for qPCR (One‐Step gDNA Removal) Kit (TransGen Biotech, AH341), which included the procedure of one‐step genomic DNA (gDNA) removal. The qPCR was analyzed using the *TransStart* Top Green qPCR SuperMix Kit (TransGen Biotech, AQ131) on the Bio‐Rad CFX Connect^TM^ Real‐Time PCR System (Bio‐Rad, CFX96 Touch). The primers that are used for the RT‐qPCR analysis are shown in Table [A5](#mbo3930-tbl-0006){ref-type="table"}, and 16S rRNA gene was used as the endogenous reference gene. The relative gene transcript level was calculated using the comparative critical threshold cycle method ($2^{- \Delta\Delta C_{t}}$). The data were presented as mean ± *SD* (standard deviation) of triplicate experiments.

2.9. Protein extraction and sample preparation {#mbo3930-sec-0011}
----------------------------------------------

To collect total proteins for mass spectrometry analysis, the cell protein extraction procedure was as follows: (a) Prepare 150‐ml fermentation medium of the *E. coli* PHY01(pCrtZYIATG), PHY01(pCrtZYI7), and PHY01(pCrtZYI9), and then the cells are harvested by centrifugation at 3,500 *g* for 10 min; (b) dissolve the cell pellet using 15 ml PBS buffer (pH 7.2) and repeat this step three times; (c) discard the supernatant and collect the pellet for the next step; (d) the collected pellet is dissolved using the 10 ml protein lysate (8 M urea, 1% DTT) and mixed well; (e) the suspension is crushed with the ultrasonic breaker (Scientz‐IID) for 10 min under ice‐bath condition; (f) the crushed suspension is centrifuged at 8,000 *g* for 15 min at 18°C; and (g) collect the supernatant into the 2‐ml centrifugal tube and repeat this step once, and the samples are stored at −80°C for analysis or protein mass spectrometry.

2.10. Statistical analysis and analytical techniques {#mbo3930-sec-0012}
----------------------------------------------------

The significance of differences between mean values of control and test samples was compared using Student\'s *t* test in the open‐source software suite "R" (<http://cran.r-project.org/>). Differences with *p* \< .05 were regarded as obvious, *p* \< .01 as significant, and *p* \< .001 as very significant. The SDS‐PAGE was run using the commercially purchased SurePageTM Gels (GenScript). The protein mass spectrometry was performed using the Orbitrap Fusion Lumos Tribrid Mass Spectrometer (LC‐MS) (Thermo Fisher), and the methods could be referred to references (Espadas, Borras, Chiva, & Sabido, [2017](#mbo3930-bib-0013){ref-type="ref"}; Li, Zhou, Xiao, Li, & Tian, [2018](#mbo3930-bib-0026){ref-type="ref"}).

3. RESULTS AND DISCUSSION {#mbo3930-sec-0013}
=========================

3.1. The expression intensity of reporter protein expression libraries with randomized NNN initiation codons {#mbo3930-sec-0014}
------------------------------------------------------------------------------------------------------------

To determine whether the expression of genes could be gradually modulated by changing their initiation codons and study the relationship between expression levels and initiation codons, reporter libraries individually expressing RFP, GFP, and lacZ with randomized NNN initiation codons were constructed in *E. coli*. The RBS core region of the pNNNrfp was AGGAG and the spacer sequence between the RBS and the initiation codon was ATATACAT (Figure [1](#mbo3930-fig-0001){ref-type="fig"}a), which was reported to be essential for translation initiation (Chen, Bjerknes, Kumar, & Jay, [1994](#mbo3930-bib-0009){ref-type="ref"}). Colonies with visually apparent diversity of expression levels were selected semi‐randomly from the pNNNrfp library on LB plates and subjected to growth and fluorescence measurement. The RFP expression levels were determined by calculating the specific fluorescence per OD~600 nm~.

![A schematic diagram of the construction of the RFP, GFP, and lacZ plasmid libraries and the corresponding experimental results. (a) The schematic diagram of pNNNrfp construction; (b) the fluorescence intensity (fluorescence/OD~600 nm~) of selected pNNNrfp strains; (c) the schematic diagram of pNNNgfp construction; (d) the fluorescence intensity (fluorescence/OD~600 nm~) of selected pNNNgfp strains; (e) the schematic diagram of pNNNlacZ construction; and (f) the β‐galactosidase activity (Miller Units) of selected pNNNlacZ strains. The data represent the means of three experiments, and the error bars represent their standard deviations.](MBO3-8-e930-g001){#mbo3930-fig-0001}

The specific fluorescence of selected strains from the pNNNrfp library is shown in Figure [1](#mbo3930-fig-0001){ref-type="fig"}b. While ATG still gave the strongest expression, the canonical initial codons of GTG and TTG had an expression strength 5% and 13% of that of ATG, respectively, which was comparable to previous reports (Beard & Spindler, [1996](#mbo3930-bib-0004){ref-type="ref"}; Rhee, Yang, Lee, & Park, [2004](#mbo3930-bib-0038){ref-type="ref"}; Stenström, Holmgren, & Isaksson, [2001](#mbo3930-bib-0045){ref-type="ref"}; Tang et al., [2017](#mbo3930-bib-0048){ref-type="ref"}). It was interesting that some of the non‐natural codons had relatively high expression levels, whereby CGC, TGG, AAA, and ACT had 26%--33% of the efficiency of ATG; GGC, ATT, and CAG initiated translation with an efficiency of 7.2%--21.6%; TTT, GTT, ACG, and TAA showed 0.1%--1.5% relative efficiency, while TAC and CAA had nondetectable fluorescence intensity. These results suggested that the randomized NNN initiation codon library had mostly evenly distributed expression levels. Moreover, even not counting the strains with nondetectable fluorescence, the library had a large dynamic range of around 3,000‐fold. A photograph of the pNNNrfp library colonies on an LB plate is shown in Figure [A1](#mbo3930-fig-0005){ref-type="fig"}a. The library of the initiation codon library of *rfp* gene (pNNNrfp) that we obtained was around four thousand colonies, and the coverage of the initiation codon library of *rfp* gene (pNNNrfp) was around 62‐fold.

To better study the quality of the expression libraries with randomized initiation codons, and investigate whether there is a universality of the relationship between expression levels and initiation codons in different contexts, reporter libraries with GFP and lacZ were also constructed and analyzed. Different RBSs, spacers, resistance markers, and constitutive promoter were used for investigating the initiation codons in different genetic contexts. In addition, we have checked the sequences of the genes we have used in this research to see whether there was in‐frame ATG, GTG, or TTG codons within the UTR region of the three reporter genes and the *crt* genes. As a result, none of ATG, GTG, and TTG codons were found. Additionally, there are no internal nature initiation codons that could shift the initial codons. The RBS core region of pNNNgfp was AGGA, and spacer sequence was AACAGCT (Figure [1](#mbo3930-fig-0001){ref-type="fig"}c). The library of the combinatorial initiation codon library of *gfp* gene (pNNNgfp) was around 5,500 colonies, and the coverage of the initiation codon library of *gfp* gene (pNNNgfp) was nearby 86‐fold. While both natural initiation codons GTG and TTG were present from the pNNNgfp library, which had an expression strength 61% and 62% of that of ATG, respectively (Figure [1](#mbo3930-fig-0001){ref-type="fig"}d), translation levels initiated by the non‐natural start codons CTC, AGC, CAC, TAT, TCG, GTT, GGA, ATC, and ATA were high and evenly distributed, ranging from 19.0% to 43.9% of that of ATG. The remaining codons AGG, CGA, GTA, GGA, ATC, TTC, TCC, and CTC had translation efficiencies in the range of 0.01%--6.5% of that of ATG, which was similar to previous reports (Hecht et al., [2017](#mbo3930-bib-0017){ref-type="ref"}; O\'Connor, Gregory, Rajbhandary, & Dahlberg, [2001](#mbo3930-bib-0032){ref-type="ref"}; Sussman, Simons, & Simons, [1996](#mbo3930-bib-0047){ref-type="ref"}). No GFP fluorescence was detected with the start codons GCA, ATT, TAG, AAG, ACT, TGC, CAA, and AAT (Figure [1](#mbo3930-fig-0001){ref-type="fig"}d).

The RBS core region of pNNNlacZ was AGGA, and the spacer sequence was AACAGCT (Figure [1](#mbo3930-fig-0001){ref-type="fig"}e). The library of the combinatorial initiation codon library of *lacZ* gene (pNNNlacZ) was around six thousand colonies, and the coverage of the initiation codon library of *lacZ* gene (pNNNlacZ) was nearby 94‐fold. The β‐galactosidase activity (Miller Units) of individual colonies was measured to evaluate *lacZ* gene expression. Among the three reporter libraries, the pNNNlacZ library had the most evenly distributed expression levels, and the natural codons GTG and TTG were also present, which had an expression strength 28.6% and 93.6% of that of ATG, respectively (Figure [1](#mbo3930-fig-0001){ref-type="fig"}f). The artificial start codons AAA, CAA, CAT, CTA, ACC, TCT, CTT, TGT, and CTG had 31.1%--73.5% of the strength of ATG, while those of the artificial start codons CAG, CGA, CCA, TGG, CGG, GAT, TGA, CCG, AGG, and GTA ranged from 0.5% to 15.7%. Interestingly, the stop codon, TGA, was found to have translation initiation efficiency of 3.0% of that of ATG (Figure [1](#mbo3930-fig-0001){ref-type="fig"}f). Only TCA and GCG had no detectable increase in β‐galactosidase activity over the control. Colonies of the pNNNlacZ library on an LB plate are shown in Figure [A1](#mbo3930-fig-0005){ref-type="fig"}b.

For studying the frequency of each non‐natural start codon in the reporter expression libraries of pNNNrfp, pNNNgfp, and pNNNlacZ, the plasmid libraries were sequenced with normal Sanger sequencing method. And the resulted ab format reporting files contain the chromatograph, the area of the peaks for A, T, C, or G semi‐quantitatively represents the frequency of bases called for a position. The regions containing initial codons are adapted into Figure [A2](#mbo3930-fig-0006){ref-type="fig"} (a, b, and c). The green peak represents the base of A, the blue peak represents the base of C, the red peak represents the base of T, and the black peak represents the base of G. These results indicated that all four bases were almost evenly represented in the initial coding region, which suggested a good coverage of the initial codon libraries.

The experimental results of the reporter protein (RFP, GFP, lacZ) expression libraries with the randomized NNN initiation codons indicated that the noncanonical start codons did not produce the same relative expression levels in different contexts. It seems that the translational initiation efficiency of initial codons has a very vague conservation. Therefore, the reporter expression strength had little predictive value. Although we did not find all the 64 possible codon triplets in each reporter library, the results indicated that some of the non‐natural initiation codons could initiate translation relatively efficiently. Thus, the expression of gene could be modulated in a gradual fashion by changing only their initiation codons, and high‐quality expression libraries could be established by replacing ATG with the NNN nucleotide oligo.

3.2. Development of a combinatorial modulation of initial codons technique for metabolic pathway optimization {#mbo3930-sec-0015}
-------------------------------------------------------------------------------------------------------------

Since random initiation codons could be employed to generate gene expression libraries, we used the CMIC technique as a simple and feasible method to modulate and optimize the expression of multiple genes simultaneously (Figure [2](#mbo3930-fig-0002){ref-type="fig"}). Variably regulated genes were obtained by PCR amplification with extended primers, in which the initiation codon nucleotides NNN were embedded at the 5′ ends. Specifically designed linkers for type II restriction enzymes were also embedded into the primers to ensure the assembly pattern and efficiency. Using the Golden Gate assembly method (Hillson et al., [2012](#mbo3930-bib-0018){ref-type="ref"}), DNA cassettes containing the pathway genes were assembled into the vector backbone to form an expression plasmid. With the above‐mentioned method, the frequency of the four bases in the initial codons of pCrtZYIlib libraries was obtained by sequencing the mixture of the library with normal Sanger sequencing method. As illustrated in Figure [A3](#mbo3930-fig-0007){ref-type="fig"} (a, b, and c), all four bases were almost evenly represented in the initial coding region, which suggested a good coverage of the initial codon libraries.

![The construction process of a CMIC library. (a) Primer design for modulating gene expression. The primers contained a *Bsa*I recognition site, optimized linkers, and the random initiation codon NNN; and (b) assembly of DNA cassettes containing modulated genes. A ready‐made vector part was used to assemble the cassettes; and (c) the structure of the CMIC library. This library contained all genes with randomized initiation codons NNN in various combinations](MBO3-8-e930-g002){#mbo3930-fig-0002}

Since each gene had a random initiation codon, a combinatorial plasmid library with variably regulated pathway genes was created, which was subsequently introduced into dedicated hosts to be screened and selected for strains carrying optimized pathways. The vector backbone was universal for all reactions, providing a stable plasmid backbone. By incorporating fixed linkers and regulatory elements into the primers for gene amplification, this method varies only the actual PCR primer sequences of pathway genes (Figure [2](#mbo3930-fig-0002){ref-type="fig"}).

3.3. Application of the CMIC technique to improve the efficiency of the zeaxanthin synthesis pathway {#mbo3930-sec-0016}
----------------------------------------------------------------------------------------------------

The experimental results of the reporter protein (RFP, GFP, lacZ) expression libraries with the randomized NNN initiation codons indicated that the noncanonical start codons did not produce the same relative expression levels with the three reporter genes in *E. coli*. Therefore, the reporter expression strength had no predictive value for the expression of the *crtZ*, *crtY,* and *crtI* genes in the zeaxanthin pathway. Consequently, we adopted a strategy of creating a de novo codon library for each *crt* gene in *E. coli*.

Zeaxanthin is synthesized from phytoene via a short pathway comprising the enzymes crtI (phytoene desaturase), crtY (lycopene β‐cyclase), and crtZ (β‐carotenoid hydroxylase) (Figures [3](#mbo3930-fig-0003){ref-type="fig"}a and [A4](#mbo3930-fig-0008){ref-type="fig"}). This synthesis pathway containing three gene products was optimized using CMIC to demonstrate a practical application of this novel technique (Figure [3](#mbo3930-fig-0003){ref-type="fig"}b). The chassis strain PHY01 (Table [A1](#mbo3930-tbl-0002){ref-type="table"}) producing the precursor of the zeaxanthin synthesis pathway, phytoene, was constructed previously using classic metabolic engineering strategies (Lu et al., [2012](#mbo3930-bib-0028){ref-type="ref"}; Sun et al., [2014](#mbo3930-bib-0046){ref-type="ref"}; Zhao et al., [2013](#mbo3930-bib-0060){ref-type="ref"}). Using the CMIC strategy, primers were designed to amplify *crtZ*, *crtY,* and *crtI* from the plasmid pYL‐crtZYI (Table [A1](#mbo3930-tbl-0002){ref-type="table"}). The designed sequences contained *Bsa*I recognition sites (GGTCTC) and specific 4‐bp linkers, as well as the random nucleotides NNN at the 5′ end of the forward primer to replace the original initiation codons. In the Golden Gate assembly reaction, the ready‐made plasmid backbone was mixed with the CDS parts *crtZ*, *crtY,* and *crtI*. After the Golden Gate assembly reaction, the plasmid library pCrtZYIlib was produced, which contained the *crtZ*, *crtY,* and *crtI* coding sequences with different initial codons in various combinations (Figure [3](#mbo3930-fig-0003){ref-type="fig"}b).

![The structure of the crtZYI CMIC library pCrtZYIlib. (a) Schematic diagram of the zeaxanthin biosynthesis pathway; and (b) the structure of the crtZYI CMIC library pCrtZYIlib](MBO3-8-e930-g003){#mbo3930-fig-0003}

The pCrtZYIlib plasmid library of around thirty thousand strains was obtained in *E. coli* DH5α on solid LB plates with 34 mg/L chloramphenicol and was subsequently transferred into the chassis strain PHY01 to obtain a combinatorial zeaxanthin production library of around thirty thousand colonies. The precursors and intermediates of the zeaxanthin pathway have different colors, with the colorless phytoene, red lycopene, orange β‐carotene, and golden yellow zeaxanthin (Figure [4](#mbo3930-fig-0004){ref-type="fig"}a). Thus, high zeaxanthin‐producing strains could be crudely prescreened visually based on the color of the colonies (Figure [4](#mbo3930-fig-0004){ref-type="fig"}b). After the first round of visual screen, the chosen strains were grown in 50‐ml flasks with 10 ml LB + 2% glycerol (v/v) at 30°C and 250 rpm for 48 hr before production analysis via HPLC.

![The photographs, zeaxanthin titers, and specific production values of selected strains from the pCrtZYIlib random‐starting‐codon library. (a) Photographs of pCrtZYIlib library colonies on an LB plate; (b) selected strains after incubation in test tubes; (c) the zeaxanthin titer of control strain PHY01(pCrtZYIATG) and nine strains, designated PHY01(pCrtZYI1) to PHY01(pCrtZY9), in fermentation medium (LB + 2% glycerol \[v/v\]); and (d) the specific zeaxanthin production value of the control strain PHY01(pCrtZYIATG) and the nine strains PHY01(pCrtZYI1) to PHY01(pCrtZY9) in fermentation medium (LB + 2% glycerol \[v/v\]). The data represent the means of three experiments, and the error bars represent their standard deviations. The significance of differences is determined using Student\'s t‐test and presented as p‐values. The asterisks indicate a significant difference compared with the control (\*\*\**p* \< .001; \*\**p* \< .01; \**p* \< .05)](MBO3-8-e930-g004){#mbo3930-fig-0004}

Nine strains with representative zeaxanthin production levels designated as PHY01(pCrtZYI1) to PHY01(pCrtZYI9) were subjected for sequencing to determine the initiation codons of the *crtZ*, *crtY,* and *crtI* genes (Tables [1](#mbo3930-tbl-0001){ref-type="table"} and [A6](#mbo3930-tbl-0007){ref-type="table"})*.* While PHY01(pCrtZYI1) to PHY01(pCrtZYI3) had lower specific zeaxanthin production values than the control strain containing the pCrtZYIATG plasmid with the original *crt* genes, PHY01(pCrtZYI4) to PHY01(pCrtZYI9) had 2.8‐ to 9.5‐fold increased zeaxanthin production (Table [1](#mbo3930-tbl-0001){ref-type="table"}). The best strain PHY01(pCrtZYI9) produced 6.33 mg/L zeaxanthin with a specific production value of 1.24 mg/g DCW (Figure [4](#mbo3930-fig-0004){ref-type="fig"}c,d), representing a 9.7‐fold and 9.5‐fold increase over the control strain (*p* \< .001).

###### 

Carotenoid production of selected strains from PHY01(pCrtZYIlib) with their corresponding initial codons of *crtZ, crtY,* and *crtI*

  Strains[a](#mbo3930-note-0003){ref-type="fn"}   Carotenoid production with different initiation codons by the multigenes of *crtZYI*                                                                                       
  ----------------------------------------------- -------------------------------------------------------------------------------------- ------------- ----- -------------- ------------- ----- -------------- ------------- -----
  PHY01(pCrtZYIATG)                               0.65 ± 0.02                                                                            0.13 ± 0.01   ATG   16.49 ± 0.09   3.35 ± 0.02   ATG   8.46 ± 0.06    1.72 ± 0.02   ATG
  PHY01(pCrtZYI1)                                 0.14 ± 0.00                                                                            0.03 ± 0.00   TAG   0.00 ± 0.00    0.00 ± 0.00   AAC   17.20 ± 0.09   3.97 ± 0.05   ATG
  PHY01(pCrtZYI2)                                 0.16 ± 0.01                                                                            0.03 ± 0.00   AAG   0.00 ± 0.00    0.00 ± 0.00   GAA   24.83 ± 0.14   4.72 ± 0.06   AAA
  PHY01(pCrtZYI3)                                 0.24 ± 0.01                                                                            0.05 ± 0.00   CCA   0.00 ± 0.00    0.00 ± 0.00   CCT   24.14 ± 0.12   4.63 ± 0.05   ATG
  PHY01(pCrtZYI4)                                 2.00 ± 0.04                                                                            0.37 ± 0.01   GGG   9.60 ± 0.04    1.76 ± 0.03   ACG   0.00 ± 0.00    0.00 ± 0.00   ATA
  PHY01(pCrtZYI5)                                 2.37 ± 0.04                                                                            0.46 ± 0.01   AGC   5.62 ± 0.04    1.10 ± 0.01   ATG   6.19 ± 0.05    1.21 ± 0.02   GTA
  PHY01(pCrtZYI6)                                 3.52 ± 0.07                                                                            0.67 ± 0.02   GTT   16.09 ± 0.10   3.07 ± 0.04   ATT   0.00 ± 0.00    0.00 ± 0.00   CTG
  PHY01(pCrtZYI7)                                 4.49 ± 0.06                                                                            0.87 ± 0.02   TCA   11.93 ± 0.05   2.32 ± 0.02   GTG   0.00 ± 0.00    0.00 ± 0.00   TTG
  PHY01(pCrtZYI8)                                 5.03 ± 0.09                                                                            0.97 ± 0.03   GAC   11.42 ± 0.06   2.21 ± 0.02   GTG   0.95 ± 0.01    0.18 ± 0.00   ACG
  PHY01(pCrtZYI9)                                 6.33 ± 0.08                                                                            1.24 ± 0.02   ACG   16.06 ± 0.06   3.15 ± 0.04   ATT   0.00 ± 0.00    0.00 ± 0.00   CTG

Three repeated experiments were performed for every strain, and the error bars represented standard deviation.

Titer = mg/L, spv = specific production value = mg/g DCW.
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It was perhaps surprising that none of the *crt* genes in the best strain PHY01(pCrtZYI9) had natural codons, indicating that the artificial codons regulated the zeaxanthin pathway more efficiently and with better balance than the original all‐ATG initiated pathway. The CMIC technique was therefore demonstrated to offer a feasible strategy for convenient metabolic pathway optimization.

An analysis of the concentrations of synthetic intermediates revealed that the low zeaxanthin‐producing strains PHY01(pCrtZYI1), PHY01(pCrtZYI2), and PHY01(pCrtZYI3) had high lycopene accumulation and no β‐carotene, suggesting that these strains had very unbalanced pathways so that the carbon flux was stopped at the first synthesis step. Conversely, most strains with improved zeaxanthin production had very low or no lycopene accumulation, but all accumulated some β‐carotene, indicating that it was beneficial to move the carbon flux to the second step of the synthesis pathway, which provided the direct substrate for zeaxanthin production.

3.4. CMIC technique modulated zeaxanthin synthesis pathway genes in translational level but not transcriptional level {#mbo3930-sec-0017}
---------------------------------------------------------------------------------------------------------------------

To determine whether the non‐ATG initial codons influenced in the transcription level or translation level of these key genes, three experiments were performed, including real‐time qPCR (RT‐qPCR) analysis, SDS‐PAGE of total proteins, and protein mass spectrometry of total proteins.

In order to investigate the relationship between non‐ATG initial codons and the transcriptional expression levels of the key carotenoid synthetic pathway genes, two representative strains PHY01(pCrtZYI7) and PHY01(pCrtZYI9) and the control strain PHY01(pCrtZYIATG) were chosen to analyze the strength of the gene expression through real‐time qPCR (RT‐qPCR). As indicated in the figures (Figures [A5](#mbo3930-fig-0009){ref-type="fig"}, [A6](#mbo3930-fig-0010){ref-type="fig"}, and [A7](#mbo3930-fig-0011){ref-type="fig"}), although with different initial codons, the transcription levels of the genes *crtI*, *crtY,* and *crtZ* were constant, which suggested that the non‐ATG codons did not affect the transcription levels of associated genes in *E. coli.*

In the SDS‐PAGE experiment, as indicated in Figure [A8](#mbo3930-fig-0012){ref-type="fig"} (a, b, and c), all three strains had their own corresponding bands matched the sizes of crtI, crtY, and crtZ proteins. Although it is difficult to distinguish clearly the brightness of crtI and crtY protein bands in the three strains, the crtZ protein band brightness of PHY01(pCrtZYI7) and PHY01(pCrtZYI9) was relative brighter than that of PHY01(pCrtZYIATG). These results indicated that in the higher zeaxanthin production, strains of PHY01(pCrtZYI7) and PHY01(pCrtZYI9) had higher crtZ protein expression than that of PHY01(pCrtZYIATG), suggested the non‐ATG initial codons affect the translation level expression of *crtZ* gene in *E. coli*.

The protein mass spectrometry was performed for determining whether the non‐ATG initial codons influence the gene translation levels expression in *E. coli*. The detailed protein mass spectrometry results of crtI, crtY, and crtZ were marked in red in Tables [A7](#mbo3930-tbl-0008){ref-type="table"}, [A8](#mbo3930-tbl-0009){ref-type="table"}, and [A9](#mbo3930-tbl-0010){ref-type="table"}. The emPAI value is used for relatively determine the protein quantity, whereas the values of Sum PEP Score, Score Sequest HT, and PSMs are used to detect the protein amount indirectly. It is demonstrated that the emPAI values of the crtZ protein in the strains of PHY01(pCrtZYI7) and PHY01(pCrtZYI9) were obviously higher than that of PHY01(pCrtZYIATG). The emPAI values of the crtY protein were nearly the same in the three strains, but the emPAI values of the crtI protein in the PHY01(pCrtZYIATG) were significantly higher than those of PHY01(pCrtZYI7) and PHY01(pCrtZYI9). Combined with RT‐qPCR data, these results proved that the non‐ATG initial codons indeed affected the gene expression in the translation level but not in the transcription levels in *E. coli*.

To understand how the different enzyme levels affect zeaxanthin production, protein mass spectrometry experiments were performed for control strain PHY01(pCrtZYIATG), which had original ATG initial codons for *crtZYI* genes, and two modulated hyper‐producing strains PHY01(pCrtZYI7) and PHY01(pCrtZYI9) with modulated initial codons. In the protein mass spectrometry results (Tables [A7](#mbo3930-tbl-0008){ref-type="table"}, [A8](#mbo3930-tbl-0009){ref-type="table"}, and [A9](#mbo3930-tbl-0010){ref-type="table"}), the quantity of detected proteins is represented by the emPAI value. It was determined from Tables [A7](#mbo3930-tbl-0008){ref-type="table"}, [A8](#mbo3930-tbl-0009){ref-type="table"}, and [A9](#mbo3930-tbl-0010){ref-type="table"} that the emPAI values of crtZ from PHY01(pCrtZYI7) and PHY01(pCrtZYI9) exhibited 5.6‐ and 7.6‐fold increase relative to the control strain PHY01(pCrtZYIATG), respectively, while crtY emPAI values remain relatively steady for the three strains. And to our surprise, emPAI values of the first enzyme in the zeaxanthin pathway, crtI, dropped significantly compared with the control strain. Previous research reports demonstrated that the crtZ enzyme was the rate‐limit step and very essential for complete conversion from β‐carotene to zeaxanthin in the biosynthesis pathway of zeaxanthin (Nishizaki, Tsuge, Itaya, Doi, & Yanagawa, [2007](#mbo3930-bib-0031){ref-type="ref"}; Pollmann, Breitenbach, & Sandmann, [2017](#mbo3930-bib-0036){ref-type="ref"}). Thus, the fact that high‐production zeaxanthin strains PHY01(pCrtZYI7) and PHY01(pCrtZYI9) exhibited significant higher crtZ (β‐carotenoid hydroxylase) enzyme levels was consistent with the previous report (Ruther, Misawa, Böger, & Sandmann, [1997](#mbo3930-bib-0039){ref-type="ref"}). However, the lower detected crtI enzyme levels in both zeaxanthin hyper‐producing strains PHY01(pCrtZYI7) and PHY01(pCrtZYI9) were not reported in related work, and we do not have a feasible explanation for it yet. However, this nonstraightforward case is worthy of investigation in future work. In addition, there is no report concerning modulating the expression of *crtZ*, *crtY,* and *crtI* simultaneously for regulating the production of zeaxanthin. Our findings here might give some clues for further optimizing the zeaxanthin synthetic pathway.

Although conventional promoter engineering is a common transcriptional regulation strategy, its disadvantages are as follows: (a) The promoters are long and have high sequence similarity, which might result in homologous recombination (Borodina & Nielsen, [2014](#mbo3930-bib-0006){ref-type="ref"}); (b) when it is the inducible promoter, large amount of the expensive inducers were essential and inevitable for using these promoters; and (c) due to the promoter sequence is too long, and the promoter strategy is complicated and tedious to operate. As for RBS‐based engineering strategies, it still has some drawbacks: (a) Sometimes there are nonspecific interactions between the 30S subunit and mRNA (Seo, Kim, & Jung, [2012](#mbo3930-bib-0042){ref-type="ref"}); and (b) the RBS sequence is relatively long and difficult to operate. Especially when combinatorial modulation techniques are performed, either promoter or RBS‐based strategies become more time‐consuming and complicated, due to several regulators are needed to be operated simultaneously.

Compared to the RBS or promoter engineering, the advantages of the CMIC approach are as follows: (a) For combinatorial modulation of several genes, the CMIC strategy costs the lowest experimental time and materials, due to only three nucleotides need to be operated for each gene, and it is feasible and has great flexibility; (b) operating the initial codons provides an extra layer for expression modulation in addition to promoters and RBSs, which might be used to further improve metabolic pathways already optimized by promoters and RBSs. And by our experiment, the improvement resulted from initial codon modulation was not marginal that the application of the CMIC strategy in *E. coli* resulting in nearly 10‐fold increased zeaxanthin production.

4. CONCLUSIONS {#mbo3930-sec-0018}
==============

This study proves that changing only the three nucleotides of the initiation codons can be used to generate expression libraries with a large dynamic range and evenly distributed expression levels in *E. coli*. Based on these findings, the novel CMIC strategy was developed for metabolic pathway optimization and applied to the zeaxanthin synthesis pathway in *E. coli*. A combinatorial library was obtained containing strains with various zeaxanthin production levels, including a strain with a 10‐fold improvement over the starting strain. Therefore, CMIC was demonstrated to be a feasible technique for conveniently optimizing metabolic pathways. To our best knowledge, this is the first metabolic engineering strategy that manipulates the initiation codons for pathway optimization in *E. coli*.

The central principle and mechanism in all organisms have been researched to be highly conserved, and *E. coli* has been used as a model organism to have revealed many principles and mechanism in classic Genetics. Thus, we think the modulation with CMIC should be universally functional to some extent in other organisms. We plan to study this strategy in a model eukaryote, *Saccharomyces cerevisiae*, to determine whether such a modulation technique could be applied to eukaryotic systems and hope to present the work in the near future.
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![The pictures of pNNNrfp library and pNNNlacZ library on LB plates. (a) pNNNrfp library on LB plates and (b) pNNNlacZ library on LB plates](MBO3-8-e930-g005){#mbo3930-fig-0005}

![The frequency of each non‐natural start codon in the reporter expression libraries. (a) The frequency of each non‐natural start codon in the reporter expression libraries of pNNNrfp; (b) the frequency of each non‐natural start codon in the reporter expression libraries of pNNNgfp; and (c) the frequency of each non‐natural start codon in the reporter expression libraries of pNNNlacZ. The green peak represents the base of A, the blue peak represents the base of C, the red peak represents the base of T, and the black peak represents the base of G](MBO3-8-e930-g006){#mbo3930-fig-0006}

![The frequency of each non‐natural start codon in the expression libraries of pCrtZYIlib. (a) The frequency of each non‐natural start codon in the expression libraries of pNNNCrtZ; (b) the frequency of each non‐natural start codon in the expression libraries of pNNNCrtY; and (c) the frequency of each non‐natural start codon in the expression libraries of pNNNCrtI. The green peak represents the base of A, the blue peak represents the base of C, the red peak represents the base of T, and the black peak represents the base of G](MBO3-8-e930-g007){#mbo3930-fig-0007}

![Biosynthesis pathway of zeaxanthin of the engineering strain PHY01(pCrtZYIlib). G‐3‐P, glyceraldehyde; DXP, 1‐deoxy‐D‐xylulose 5‐phosphate; MEP, methyl‐[d]{.smallcaps}‐erythritol 4‐phosphate; IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; GPP, geranyl pyrophosphate; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate](MBO3-8-e930-g008){#mbo3930-fig-0008}

![The relative transcriptional level of *crtI* gene in the strains of control strain PHY01(pCrtZYIATG), and experimental strains of PHY01(pCrtZYI7) and PHY01(pCrtZYI9). 16S rRNA was used as the endogenous reference gene. The data were shown as mean ± standard deviation (*SD*) of three independent experiments](MBO3-8-e930-g009){#mbo3930-fig-0009}

![The relative transcriptional level of *crtY* gene in the strains of control strain PHY01(pCrtZYIATG), and experimental strains of PHY01(pCrtZYI7) and PHY01(pCrtZYI9). 16S rRNA was used as the endogenous reference gene. The data were shown as mean ± standard deviation (*SD*) of three independent experiments](MBO3-8-e930-g010){#mbo3930-fig-0010}

![The relative transcriptional level of *crtZ* gene in the strains of control strain PHY01(pCrtZYIATG), and experimental strains of PHY01(pCrtZYI7) and PHY01(pCrtZYI9). 16S rRNA was used as the endogenous reference gene. The data were shown as mean ± standard deviation (*SD*) of three independent experiments](MBO3-8-e930-g011){#mbo3930-fig-0011}

![The SDS‐PAGE photograph of the proteins which were extracted from the control strain PHY01(pCrtZYIATG), and the experimental strains of PHY01(pCrtZYI7) and PHY01(pCrtZYI9). Figure (a--c) represented three repeated experiments](MBO3-8-e930-g012){#mbo3930-fig-0012}

###### 

*E. coli* strains and plasmids used in this study

  Name         Characteristics                                                                                                                    Sources
  ------------ ---------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------
  Strains                                                                                                                                         
  DH5α         F‐Φ80lacZΔM15 Δ(lacZYA‐argF) U169 recA1 endA1 hsdR17(rk−, mk+) phoA supE44 thi‐1 gyrA96 relA1 λ‐                                   Invitrogen
  MG1655       Wild type                                                                                                                          Laboratory stored
  M1‐46        ATCC8739, FRT‐Km‐FRT::M1‐46::lacZ                                                                                                  Lu et al. [2012](#mbo3930-bib-0028){ref-type="ref"}
  M1‐36        ATCC8739, FRT‐Km‐FRT::M1‐36::lacZ                                                                                                  Laboratory stored
  PHY01        ATCC 8739, ldhA::RBSL9::crtEB, RBSL12::dxs, RBSL7::idi, M1‐46::sucAB, M1‐46::sdhABCD, M1‐46::talB, mRSL‐4:: ispG, mRSL‐14:: ispH   Laboratory stored
  Plasmids                                                                                                                                        
  pBBR1‐rfp    kan; pBBR1 replicon; RFP                                                                                                           Laboratory stored
  p034apr      apr; pMB1 replicon                                                                                                                 Laboratory stored
  pQE60‐gfp    bla; pSC101 Origin1 replicon; GFP                                                                                                  Laboratory stored
  pYL‐crtZYI   cat; pSC101 replicon; *crtZYI* genes cloned into pYL vector                                                                        Laboratory stored
  pNNNrfp      kan, pBBR1 replicon; RFP‐NNN                                                                                                       This work
  pNNNgfp      apr; pMB1 replicon; GFP‐NNN                                                                                                        This work
  pNNNlacZ     apr; pMB1 replicon; lacZ‐NNN                                                                                                       This work
  pCrtZYIATG   Cm; pSC101 replicon; crtZ‐ATG, crtY‐ATG, crtI‐ATG                                                                                  This work
  pCrtZYIlib   Cm, pSC101 replicon; crtZ‐NNN, crtY‐NNN, crtI‐NNN                                                                                  This work
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###### 

Sequences of promoters BBa J23100, P46, and P36, and sequences of RBS of *rfp*, *gfp*, *lacZ,* and *crt ZYI*

  Name            Sequences
  --------------- -------------------------------------------------------------------------------------
  BBa J23100      [a](#mbo3930-note-0005){ref-type="fn"} **TTGACG**GCTAGCTCAGTCCTAGG**TACAGT**GCTAGC
  RBS of *rfp*    TTTAAGAAGGAGATATACAT
  P46             TTATCTCTGGCGGTG**TTGACA**AGAGATAACAACGTTGA**TATAAT**TGAGCCTCTCGCCCCACCAATTCGGTTTAAA
  RBS of *gfp*    CCAGGAAACAGCT
  RBS of *lacZ*   CCAGGAAACAGCT
  P36             CAGAAAAAAAGATCAAAAAAATAC**TTGTGC**AAAAAATTGGGATCCC**TATAAT**GCGCCTCCGTTGAGACGAATAA
  RBS of *crtZ*   CAATTTCACACAGGAGATCATAA
  RBS of *crtY*   ATAAAGGAGGTAAAAT
  RBS of *crtI*   ATAAAGGAGGATAATA

The bold fonts represented −35 and −10 sequences in different promoters.
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###### 

Primers used in this study

  Prime name                                            Sequence
  ----------------------------------------------------- ----------------------------------------------------
  Construction of pNNNrfp initiation codon library      
  pBBR1‐rfp‐F                                           CCAGGTCTCAACATNNNGCGAGTAGCGAAGACG
  pBBR1‐rfp‐R                                           CCAGGTCTCAATGTATATCTCCTTCTTAAAGCTAGCACTGTACC
  Construction of pNNNgfp initiation codon library      
  pMB1_apr_F                                            CCAGGTCTCAAGCGACAGATCGCTGAGATAG
  pMB1_apr_R                                            CCAGGTCTCAGAGCAGACTTGACCTGATAG
  P46‐up                                                CCAGGTCTCAGCTCTTATCTCTGGCGGTGTTGAC
  GFP_RBS‐down                                          CCAGGTCTCATACCNNNAGCTGTTTCCTGGTT
  Gfp_F                                                 CCAGGTCTCAGGTAAGGGAGAAGAACTTTTCACTGG
  Gfp_R                                                 CCAGGTCTCACGCTCCGAGCGTTCTGAACAAATC
  Construction of pNNNlacZ initiation codon library     
  pMB1_apr_F                                            CCAGGTCTCA AGCG ACAGATCGCTGAGATAG
  pMB1_apr_R                                            CCAGGTCTCA GAGC AGACTTGACCTGATAG
  P46‐up                                                CCAGGTCTCA GCTC TTATCTCTGGCGGTGTTGAC
  lacZ_RBS‐down                                         CCAGGTCTCA TGGT NNNAGCTGTTTCCTGGTT
  LacZ_F                                                CCAGGTCTCA ACCA TGATTACGGATTCACTGGCCG
  LacZ_R                                                CCAGGTCTCA CGCT ACGCGAAATACGGGCAGAC
  Construction of pCrtZYIlib initiation codon library   
  crt‐F                                                 CCAGGTCTCACGCAGAAGCGGTCTGATAAAACAG
  crt‐R                                                 CCAGGTCTCAGTAGTGCCATTTACCCCCATTCAC
  P36‐F                                                 CCAGGTCTCACTAC CAGAAAAAAAGATCAAAAAAATAC
  P36‐R                                                 CCAGGTCTCAGATCTCCTGTGTGAAATTGTTATTCGT
  crtZ‐F                                                CCAGGTCTCAGATCATAANNNTTGTGGATTTGGAATGCCCTG
  crtZ‐R                                                CCAGGTCTCATACCTCCTTTATTTACTTCCCGGGTGGCGCGTCACG
  crtY‐F                                                CCAGGTCTCAGGTAAAATNNNCCGCGGTATGATCTGATTCTGGTGG
  crtY‐R                                                CCAGGTCTCAATCCTCCTTTATTTACATCGCCTGTTGACGGTGAGG
  crtI‐F                                                CCAGGTCTCAGGATAATANNNAATAGAACTACAGTAATTGGCGCAGGCTT
  crtI‐R                                                CCAGGTCTCATGCG TCAAGCCAGATCCTCCAGCATCAA
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###### 

Sequencing primers of plasmids and PCR products

  Primer name                                  Sequence
  -------------------------------------------- ------------------------
  Sequencing primers of pNNNrfp                
  rfpp‐F                                       GAAGCCGGTCTTGTCGATCAGG
  rfpp‐R                                       GGGCCGTTGAATCGGGATATGC
  Sequencing primers of pNNNgfp and pNNNlacZ   
  capr‐F                                       GGGCCGAGATCCGTTGAT
  capr‐R                                       TCTTCACCTAGATCCTTT
  Sequencing primers of pCrtZYIlib             
  crtZ‐C                                       CTCGCAAGCTCGGGCAAA
  crtY‐C                                       ATTCCGCTATGTTCCGCG
  crtI‐C                                       CGCATGCTGAACCGTATG
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###### 

The primers that used for the real‐time qPCR

  Primer name                            Sequence
  -------------------------------------- ------------------------
  Primers of endogenous reference gene   
  16S‐F                                  CATCCTGAACCACTGACCAG
  16S‐R                                  AGCACCTTCACTTCCACG
  Primers of crtI, crtY, and crtZ        
  crtI‐qPCR‐F                            GCCACTTCCTCAATCTATACCC
  crtI‐qPCR‐R                            TAATCCTGTTTTCCTGGGTCTC
  crtY‐qPCR‐F                            GGAGAGTGACGCAGTGATTG
  crtY‐qPCR‐R                            TGTAGACAAAGCGATAGCCTG
  crtZ‐qPCR‐F                            TGTTCTGGTCACTGTTATCGG
  crtZ‐qPCR‐R                            GTCATTAACCTCAAACCAGCC
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###### 

Initiation codons of *crtZ*, *crtY,* and *crtI* from selected strains from PHY01(pCrtZYIlib)

  Strains             Initiation codon         
  ------------------- ------------------ ----- -----
  PHY01(pCrtZYIATG)   ATG                ATG   ATG
  PHY01(pCrtZYI1)     TAG                AAC   ATG
  PHY01(pCrtZYI2)     AAG                GAA   AAA
  PHY01(pCrtZYI3)     CCA                CCT   ATG
  PHY01(pCrtZYI4)     GGG                ACG   ATA
  PHY01(pCrtZYI5)     AGC                ATG   GTA
  PHY01(pCrtZYI6)     GTT                ATT   CTG
  PHY01(pCrtZYI7)     TCA                GTG   TTG
  PHY01(pCrtZYI8)     GAC                GTG   ACG
  PHY01(pCrtZYI9)     ACG                ATT   CTG
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###### 

The protein mass spectrometry result for the determination of crtI, crtY, and crtZ protein expression by the engineered *E. coli* strain PHY01(pCrtZYIATG)

  Accession   Description                                                               Sum PEP Score   Coverage   \#PSMs   \#AAs   MW\[kDa\]   calc.PI   emPAI   Score Sequest HT
  ----------- ------------------------------------------------------------------------- --------------- ---------- -------- ------- ----------- --------- ------- ------------------
  P0A698      UvrABC system protein A OS = *Escherichia coli* (strain K12)              42.24666618     7.97872    8        940     103.803     6.64      0.407   27.36333418
  sp          006 CrtI                                                                  151.3272627     25.4065    19       492     54.769      6.77      3.52    102.4008672
  P0A9C0      Anaerobic glycerol‐3‐phosphate dehydrogenase subunit A OS = Esc           68.23289629     27.1218    16       542     58.921      6.64      1.202   57.84568882
  P0AB71      Fructose‐bisphosphate aldolase class 2 OS = *Escherichia coli*            33.73338241     24.5125    7        359     39.123      5.86      1.581   26.53024399
  P11349      Respiratory nitrate reductase 1 beta chain OS = *Escherichia coli*        29.23611516     9.375      4        512     58.029      6.77      0.311   20.04963112
  sp          007 CrtY                                                                  86.47902161     45.0777    16       386     43.604      8         3.962   63.83823073
  P0A794      Pyridoxine 5′‐phosphate synthase OS = *Escherichia coli* (strain K12)     38.62064587     16.0494    5        243     26.368      5.95      1.276   25.20745921
  P75691      Aldehyde reductase YahK OS = *Escherichia coli* (strain K12)              35.94943889     14.3266    6        349     37.954      6.23      0.995   24.27691317
  P0AB77      2‐amino‐3‐ketobutyrate coenzyme A ligase OS = *Escherichia coli*          23.08778624     9.79899    4        398     43.09       5.97      0.551   15.84744815
  sp          008 CrtZ                                                                  28.64109322     28.9763    8        175     20.168      9.9       1.287   58.87265334
  P0AEC3      Aerobic respiration control sensor protein ArcB OS = *Escherichia coli*   4.008818242     1.41388    1        778     87.928      5.1       0.058   3.146479845
  P77611      Electron transport complex subunit RsxC OS = *Escherichia*                7.615976868     7.2973     2        740     80.122      8.63      0.105   4.493131638
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###### 

The protein mass spectrometry result for the determination of crtI, crtY, and crtZ protein expression by the engineered *E. coli* strain PHY01(pCrtZYI7)

  Accession   Description                                                               Sum PEP Score   Coverage   \#PSMs   \#AAs   MW\[kDa\]   calc.PI   emPAI   Score Sequest HT
  ----------- ------------------------------------------------------------------------- --------------- ---------- -------- ------- ----------- --------- ------- ------------------
  P0A698      UvrABC system protein A OS = *Escherichia coli* (strain K12)              42.24666618     7.97872    8        940     103.803     6.64      0.407   27.36333418
  sp          006 CrtI                                                                  42.00374291     5.4878     5        492     54.769      6.77      0.487   26.96346498
  P0A9C0      Anaerobic glycerol‐3‐phosphate dehydrogenase subunit A OS = Esc           108.0647275     32.6568    23       542     58.921      6.64      2.06    83.88820601
  P0AB71      Fructose‐bisphosphate aldolase class 2 OS = *Escherichia coli*            97.09414663     29.2479    11       359     39.123      5.86      3.437   53.46555638
  P11349      Respiratory nitrate reductase 1 beta chain OS = *Escherichia coli*        86.5361797      24.6094    16       512     58.029      6.77      1.581   63.89301682
  sp          007 CrtY                                                                  72.35807128     40.1237    12       386     43.604      8         3.276   51.25720981
  P0A794      Pyridoxine 5′‐phosphate synthase OS = *Escherichia coli* (strain K12)     65.53282216     16.4609    7        243     26.368      5.95      2.162   39.8662715
  P75691      Aldehyde reductase YahK OS = *Escherichia coli* (strain K12)              57.03702369     23.7822    10       349     37.954      6.23      1.512   45.17795205
  P0AB77      2‐amino‐3‐ketobutyrate coenzyme A ligase OS = *Escherichia coli*          46.90887079     20.603     8        398     43.09       5.97      1.404   35.01567221
  sp          008 CrtZ                                                                  198.3765561     41.5692    8        175     20.168      9.9       7.256   227.63115
  P0AEC3      Aerobic respiration control sensor protein ArcB OS = *Escherichia coli*   4.97510404      1.41388    1        778     87.928      5.1       0.058   3.045333862
  P77611      Electron transport complex subunit RsxC OS = *Escherichia*                3.865271223     4.86486    2        740     80.122      8.63      0.105   3.155004501
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###### 

The protein mass spectrometry result for the determination of crtI, crtY, and crtZ protein expression by the engineered *E. coli* strain PHY01(pCrtZYI9)

  Accession   Description                                                               Sum PEP Score   Coverage   \#PSMs   \#AAs   MW\[kDa\]   calc.PI   emPAI   Score sequest HT
  ----------- ------------------------------------------------------------------------- --------------- ---------- -------- ------- ----------- --------- ------- ------------------
  P0A698      UvrABC system protein A OS = *Escherichia coli* (strain K12)              47.00549802     9.57447    10       940     103.803     6.64      0.407   35.69448233
  sp          006 CrtI                                                                  37.11252812     7.98889    7        492     54.769      6.77      0.398   23.78128947
  P0A9C0      Anaerobic glycerol‐3‐phosphate dehydrogenase subunit A OS = Esc           61.79982658     23.2472    12       542     58.921      6.64      0.931   45.54526341
  P0AB71      Fructose‐bisphosphate aldolase class 2 OS = *Escherichia coli*            32.91694772     29.2479    7        359     39.123      5.86      1.581   25.66632211
  P11349      Respiratory nitrate reductase 1 beta chain OS = *Escherichia coli*        41.07101889     17.3828    6        512     58.029      6.77      0.501   27.12277055
  sp          007 CrtY                                                                  48.49429593     12.9534    10       386     43.604      8         2.15    33.47542071
  P0A794      Pyridoxine 5'‐phosphate synthase OS = *Escherichia coli* (strain K12)     57.17310024     29.2181    9        243     26.368      5.95      3.394   40.71503448
  P75691      Aldehyde reductase YahK OS = *Escherichia coli* (strain K12)              51.91666791     23.4957    8        349     37.954      6.23      1.512   34.80960083
  P0AB77      2‐amino‐3‐ketobutyrate coenzyme A ligase OS = *Escherichia coli*          5.276033776     10.5528    3        398     43.09       5.97      0.389   4.364562869
  sp          008 CrtZ                                                                  297.3973216     36.7087    10       175     20.168      9.9       9.849   356.2761002
  P0AEC3      Aerobic respiration control sensor protein ArcB OS = *Escherichia coli*   15.77476879     6.94087    4        778     87.928      5.1       0.252   12.87201095
  P77611      Electron transport complex subunit RsxC OS = *Escherichia*                12.40281299     4.86486    2        740     80.122      8.63      0.105   7.91286993
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